- Home
- RAPT vs CXDO Comparison
RAPT vs CXDO Comparison
Compare RAPT & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CXDO
- Stock Information
- Founded
- RAPT 2015
- CXDO 1995
- Country
- RAPT United States
- CXDO United States
- Employees
- RAPT N/A
- CXDO N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CXDO Telecommunications Equipment
- Sector
- RAPT Health Care
- CXDO Telecommunications
- Exchange
- RAPT Nasdaq
- CXDO Nasdaq
- Market Cap
- RAPT 194.2M
- CXDO 198.8M
- IPO Year
- RAPT 2019
- CXDO 1998
- Fundamental
- Price
- RAPT $26.62
- CXDO $6.74
- Analyst Decision
- RAPT Buy
- CXDO Strong Buy
- Analyst Count
- RAPT 6
- CXDO 4
- Target Price
- RAPT $34.17
- CXDO $8.75
- AVG Volume (30 Days)
- RAPT 180.1K
- CXDO 138.3K
- Earning Date
- RAPT 11-11-2025
- CXDO 11-05-2025
- Dividend Yield
- RAPT N/A
- CXDO N/A
- EPS Growth
- RAPT N/A
- CXDO 13.31
- EPS
- RAPT N/A
- CXDO 0.11
- Revenue
- RAPT N/A
- CXDO $64,476,000.00
- Revenue This Year
- RAPT N/A
- CXDO $13.46
- Revenue Next Year
- RAPT N/A
- CXDO $11.27
- P/E Ratio
- RAPT N/A
- CXDO $61.26
- Revenue Growth
- RAPT N/A
- CXDO 13.10
- 52 Week Low
- RAPT $5.67
- CXDO $3.75
- 52 Week High
- RAPT $27.74
- CXDO $7.34
- Technical
- Relative Strength Index (RSI)
- RAPT 89.76
- CXDO 55.08
- Support Level
- RAPT $18.08
- CXDO $6.41
- Resistance Level
- RAPT $21.29
- CXDO $7.01
- Average True Range (ATR)
- RAPT 1.91
- CXDO 0.30
- MACD
- RAPT 0.91
- CXDO -0.03
- Stochastic Oscillator
- RAPT 92.12
- CXDO 57.81
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.